These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 9892091)
1. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas. Kim JH; Lee SH; Rhee CH; Park SY; Lee JH J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091 [TBL] [Abstract][Full Text] [Related]
2. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10. Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312 [TBL] [Abstract][Full Text] [Related]
3. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212 [TBL] [Abstract][Full Text] [Related]
4. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725 [TBL] [Abstract][Full Text] [Related]
6. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292 [TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131 [TBL] [Abstract][Full Text] [Related]
8. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Lindblom A; Ruttledge M; Collins VP; Nordenskjöld M; Dumanski JP Int J Cancer; 1994 Feb; 56(3):354-7. PubMed ID: 8314321 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323 [TBL] [Abstract][Full Text] [Related]
12. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307 [TBL] [Abstract][Full Text] [Related]
13. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247 [TBL] [Abstract][Full Text] [Related]
14. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357 [TBL] [Abstract][Full Text] [Related]
15. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. Baser ME; Poussaint TY J Med Genet; 2006 Mar; 43(3):285-7. PubMed ID: 15980114 [TBL] [Abstract][Full Text] [Related]
16. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA; Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516 [TBL] [Abstract][Full Text] [Related]
17. Allelic loss at 1p is associated with tumor progression of meningiomas. Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053 [TBL] [Abstract][Full Text] [Related]
18. Search for putative suppressor genes in meningioma: significance of chromosome 22. Schneider G; Lutz S; Henn W; Zang KD; Blin N Hum Genet; 1992 Mar; 88(5):579-82. PubMed ID: 1551661 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744 [TBL] [Abstract][Full Text] [Related]
20. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]